1. Univariate and classification analysis reveals potential diagnostic biomarkers for early stage ovarian cancer Type 1 and Type 2
   Simonas Marcišauskas et al, 2019, Journal of Proteomics CrossRef
2. Tubulin Beta 2C Chain (TBB2C), a Potential Marker of Ovarian Cancer, an Insight from Ovarian Cancer Proteome Profile
   Shahzadi Noreen et al, 2021, ACS Omega CrossRef
3. Plasma Gelsolin Reinforces the Diagnostic Value of FGF-21 and GDF-15 for Mitochondrial Disorders
   Ana Peñas et al, 2021, International Journal of Molecular Sciences CrossRef
4. Construction and validation of a prognostic risk model for breast cancer based on protein expression
   Bo Huang et al, 2022, BMC Medical Genomics CrossRef
5. Characterization of ovarian cancer cells and tissues by Fourier transform infrared spectroscopy
   Lei Li et al, 2018, Journal of Ovarian Research CrossRef
6. Label-Free Quantification Mass Spectrometry Identifies Protein Markers of Chemotherapy Response in High-Grade Serous Ovarian Cancer
   Georgia Arentz et al, 2023, Cancers CrossRef
7. Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics
   Eisuke Miyauchi et al, 2018, PLOS ONE CrossRef
8. Role of lncRNA‑ATB in ovarian cancer and its mechanisms of action
   Donglan Yuan et al, 2019, Experimental and Therapeutic Medicine CrossRef
9. Targeted Selected Reaction Monitoring Verifies Histology Specific Peptide Signatures in Epithelial Ovarian Cancer
   Leena Liljedahl et al, 2021, Cancers CrossRef
10. Platelet protein biomarker panel for ovarian cancer diagnosis
    Marta Lomnytska et al, 2018, Biomarker Research CrossRef
11. The role of tumor-educated platelets in ovarian cancer: A comprehensive review and update
    Dimple Patel et al, 2023, Pathology - Research and Practice CrossRef
12. Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target
    Ewelina Piktel et al, 2018, International Journal of Molecular Sciences CrossRef